We’re highlighting the importance of early action to help prevent irreversible organ damage in people with lupus. Global experts are recognising the extensive data to support the timely use of evidence-based treatments to help reduce the risk of permanent kidney damage. Learn more at our dedicated GSK site: https://gsk.to/3L15zew
About us
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
- Website
-
http://www.gsk.com
External link for GSK
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Brentford, Middlesex
- Type
- Public Company
- Specialties
- Pharmaceutical products and Vaccines
Locations
Employees at GSK
Updates
-
Today, we’ve signed a new 10-year energy deal in Singapore with Sembcorp which is set to increase our global purchased renewable electricity usage by 9% from 2025. With this new agreement, all three of our medicines and vaccines manufacturing sites in Singapore will be covered by 100% renewable electricity generated directly at the site and purchased through renewable energy certificates from solar projects. Our sites in Singapore are critical for the production of innovative medicines and vaccines for HIV, oncology and infectious diseases. We know that climate change is already having a negative impact on human health, and we are committed to playing our part in protecting the health of both people and the planet to help get ahead of disease together. #LCAW2024
-
"Can we end epidemics?" is a brand new 6-episode podcast series from ViiV Healthcare, in partnership with Foreign Policy. Episode 5, ‘Reaching New Heights,’ brings together GSK’s Fiona Smith-Laittan and AMREF’s Dr Mercy Mwangangi to discuss: 🌍 What it takes to deliver health impact at scale? 💡 Why must global health innovation be accelerated? 🤝 And how can partnerships help build, strengthen and future-proof health systems? Take a listen wherever you get your podcasts! Or find out more, here: https://gsk.to/3RHnk6s
-
Healthy people need a healthy planet. That’s why we’re using science, technology and talent to help deliver our ambitious sustainability goals. By including climate and nature considerations in product discovery and development, GSK people are working together to design our medicines and vaccines to be more sustainable from the start. Meet Zack, an inspired GSK chemist, early riser and planet protector, working on green chemistry solutions to minimise waste, reduce our energy use and improve productivity. Through cutting-edge research, Zack and his team are working to develop more sustainable medicines and vaccines to benefit patients and the planet. Learn more at https://lnkd.in/dvmG8r75 and explore career opportunities at https://lnkd.in/eztbEUd. #GSKCareers #WeAreGSK #LCAW2024
-
This London Climate Action Week we’re focused on how we’re working across our business, and together with our suppliers and partners, to develop more sustainable medicines and vaccines. We’re harnessing the very best of GSK’s science, technology and talent, from using our scientific expertise to help to make our new products sustainable by design, to transitioning to renewable energy to power our manufacturing sites. Stay tuned for updates throughout the week and learn more about the work we’re already doing to support healthcare systems that are better for patients and better for the planet. https://gsk.to/4eCmqly #LCAW2024
-
-
#News for #Investors and #Media: Today, we announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted approval for our blood cancer therapy. Learn more: https://gsk.to/3VT5pMC
-
#News for #Investors and #Media: Today, we announced that our marketing authorisation application for a potential expanded indication for our immuno-oncology therapy has been validated by the European Medicines Agency (EMA). Learn more: https://gsk.to/4carMTi
-
Next week is London Climate Action Week and we’re excited to be part of the conversation by sharing how we’re working to deliver more sustainable medicines and vaccines, to support healthcare systems that are better for patients and the planet. We’re working to power our manufacturing sites with renewable energy and just last week, we completed a major renewable energy project at our site in Irvine, Scotland. We successfully connected the site to the electricity generated from two wind turbines and a solar farm, a step that is set to triple the renewable electricity generated onsite. We’ll be sharing more updates on the action we’re taking to help decarbonize healthcare systems at #LCAW2024.
-
At GSK, we’re passionate about turning science and technology into solutions that can get ahead of disease. More than 60 years ago, the respiratory syncytial virus (RSV) was identified by scientists but it took decades of research to have more choices for the prevention of RSV to help protect those most at risk of severe RSV disease. As our knowledge of RSV continues to grow, we are committed to helping raise awareness of the importance of protecting those most at risk of RSV. Our goal is help people enjoy life at its fullest!